"Calimmune is also developing a rich product candidate pipeline to address the needs of different types of individuals at different states of HIV infection and with different levels of treatment experience."
One would think they won't be curing but will be controlling this disease. I wouldn't be banking on anything from Cal-1 for a while.
Thinking that a partnership will come for the ling cancer and provide upfront monies we have ready spent, that might save the day mid year.
- Forums
- ASX - By Stock
- BLT
- benitec/calimmune sydney presentation
benitec/calimmune sydney presentation, page-13
-
- There are more pages in this discussion • 23 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)